Saptalis Pharmaceuticals
Hauppauge, US · Founded 2015 · Delaware LLC
Founders & leadership
PD
Polireddy DondetiNamed on SEC filing
TA
Tatiana AkimovaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 2 rounds · 2015–2016
▶$6.5MraisedNov 2016 · 7 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedNov 2016 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Polireddy DondetiExecutive Officer, Director
- Tatiana AkimovaExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Oct 2016
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$3MraisedSep 2015 · 3 investors · PharmaceuticalsRule 506(b)
▶$3MraisedSep 2015 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Polireddy DondetiExecutive Officer, Director
- Tatiana AkimovaExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Sep 2015
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Saptalis Pharmaceuticals raised?
- Saptalis Pharmaceuticals has disclosed $9.5M raised across 2 rounds.
- Where is Saptalis Pharmaceuticals headquartered?
- Saptalis Pharmaceuticals is headquartered in Hauppauge, US.